Back
Huron Consulting Group, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
77
HURN
Huron Consulting Group, Inc.
Last Price:
$178.69
Seasonality Move:
2.6%
Sell
29
ZBIO
Zenas BioPharma, Inc.
Last Price:
$34.77
Seasonality Move:
0.59%
Buy
77
Huron Consulting Group, Inc. (HURN)
is a Buy
Is Huron Consulting Group, Inc. a Buy, Sell or Hold?
-
The current Huron Consulting Group, Inc. [HURN] share price is $179.70. The Score for HURN is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
HURN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HURN Stock Price Chart
What is Huron Consulting Group, Inc.'s stock price today?
-
The Huron Consulting Group, Inc. share price today is $179.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HURN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $35.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.
HURN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.88 | Buy |
| Relative Strength Index (14 RSI): | 75.08 | Buy |
| Chaikin Money Flow: | 121177 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (161.93 - 174.55) | Buy |
| Bollinger Bands (100): | (136.09 - 164.89) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 49.55 | Sell |
| Chaikin Money Flow: | -89322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.22 - 39.36) | Sell |
| Bollinger Bands (100): | (17.16 - 33.88) | Buy |
HURN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 176.38 | Buy |
| 20-day SMA: | 169.58 | Buy |
| 50-day SMA: | 162.53 | Buy |
| 200-day SMA: | 145.86 | Buy |
| 8-day EMA: | 176.41 | Buy |
| 20-day EMA: | 171.4 | Buy |
| 50-day EMA: | 163.45 | Buy |
| 200-day EMA: | 145.93 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.84 | Sell |
| 20-day SMA: | 37.69 | Sell |
| 50-day SMA: | 32.84 | Buy |
| 200-day SMA: | 17.75 | Buy |
| 8-day EMA: | 7.96 | Buy |
| 20-day EMA: | 3.41 | Buy |
| 50-day EMA: | 1.4 | Buy |
| 200-day EMA: | 0.36 | Buy |
Huron Consulting Group, Inc. Earnings Growth & HURN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.06 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Huron Consulting Group, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||